Hiv/aids Patients Also Have An Increased Risk Of Several Cancers
In some cases these cancer risks are due to other factors commonly associated with HIV/AIDS. For example, smoking is more common among HIV/AIDS patients, and the increased smoking rate among HIV/AIDS patients may account for much of the increased incidence of lung cancer among that population. However, other cancers appear to be more common as a result of HIV infection and disease progression.
Because HIV primarily targets immune cells, HIV/AIDS can lead to lymphoma, which is a cancer of the white blood cells.Another cancer common in HIV/AIDS patients and rare in uninfected people is Kaposis sarcoma. This cancer affects blood vessels and causes the characteristic reddish lesions that have often been associated with AIDS patients. Other cancers, including Hodgkin disease and testicular seminoma also appear to occur at a higher frequency in HIV/AIDS patients as a result of decreased immune function 8.
Questions To Ask About Each Drug
One of the most important things you can do to make sure you take your medicine correctly is to talk with your medical provider about your lifestyle, such as your sleeping and eating schedule. If your provider prescribes a drug, be sure and ask the following questions :
- What dose of the drug should be taken? How many pills does this mean?
- How often should the drug be taken?
- Does it matter if it is taken with food, or on an empty stomach?
- Does the drug have to be kept in a refrigerator?
- What are the possible side effects of the drug?
- What should be done to deal with the side effects?
- How severe do side effects have to be before a provider is called?
During every medical visit you should talk about whether you are having trouble staying on your treatment plan. Studies show that people who take their medicine in the right way get the best results: their viral loads stay down, their CD4 counts stay up, and they feel healthier.
Learning Objective Performance Indicators
- List the major classes of antiretroviral medications and describe the mechanism of action with each class of drugs
- Discuss evidence supporting antiretroviral treatment of all persons with HIV
- List recommended antiretroviral regimens for treatment-naïve individuals and discuss factors to consider when selecting an initial regimen
- Summarize recommended laboratory studies to obtain at baseline and while monitoring response to therapy
You May Like: Which Country Has The Highest Hiv Rate
Will There Ever Be A Cure For Hiv
Researchers and scientists believe we can find a cure for HIV. We know a lot about HIV, as much as certain cancers. Scientists are researching two types of cure: a functional cure and a sterilising cure.
There is no ‘natural cure’ or ‘herbal cure’ for HIV. Antiretroviral treatment is the only medication that is proven to effectively control HIV.
Hiv Transmission In Drug Users
For people who inject drugs, estimates of the risk of transmission from a contaminated needle range from 0.3% to 4.0%, with several of these estimates falling in the range of 0.7% to 0.8%. Sharing ancillary injecting equipment, such as filters or cookers, has been shown to increase the risk of transmission, even in the absence of sharing needles and syringes. Other factors that have been shown to increase the risk of HIV transmission for injection drug users include: unsafe locations, type of drug and frequency of drug injection. Non-injection drug users are also at risk of HIV infection. Drug use often alters sexual behaviours by increasing risk taking. As well, several drugs have been reported to be independent risk factors of HIV transmission.
Recommended Reading: What Is The Percentage Of Hiv In America
What Are Drug Interactions
Your HIV medications can be affected by other medicines, including other prescription drugs you are taking and drugs you buy over the counter at a pharmacy. Even herbal therapies, nutritional supplements, and some things found in common foods can affect your HIV medicines.
When one drug affects how another drug behaves, this is called a drug-drug interaction. For example, some drugs become less effective or cause side effects when they are taken with certain other drugs.
When something in food affects how a drug behaves, it is called a drug-food interaction. For example, grapefruit juice, taken at the same time as certain drugs, can boost the amount of these drugs in your bloodstream to an undesirable level. Everyone taking HIV drugs needs to be very careful about these interactions. Luckily, many of these interactions are well known to your provider and can be managed.
Your provider can give you a list of drugs and foods to avoid, depending on what treatment you are taking. Ask for this information for each drug that you are taking.
Also, be sure that you tell your provider about every single medication, drug, supplement, and herb you are taking–whether you got them by prescription or not.
Should You Ever Switch The Drugs You’re Taking
You should never change the drug plan you’re on without talking with your provider. This is a very important decision and one that must be made with your provider.
There are a few reasons that your provider may suggest you change your medicines. There may be a fixed-dose combination pill that could simplify your therapy. Or your treatment may not be working well enough and you may need different medicines. Or you may have side effects that are bothering you, or lab tests that show signs of ill effects from the HIV drugs .
Before changing medicines, you and your provider should talk about:
- All the HIV drugs you have taken before and the ones you haven’t taken
- Any drug resistance your HIV virus may have
- Possible side effects of the new medicines
- How well you will be able to follow the new drug treatment plan
Always be sure to talk with your provider about any changes in your drug treatment.
Don’t Miss: How Is Hiv Transmitted Through Blood
Hiv Entry And Entry Inhibitors
The initial step in the HIV life cycle involves a complex interaction between HIV envelope spikes and host surface proteins. The HIV envelope consists of two structural components: surface envelope glycoprotein and transmembrane envelope glycoprotein . The surface of HIV is studded with approximately 14 envelope spikes, with each spike consisting of a trimer of three gp120 and gp41 subunits . Both gp120 and gp41 play an essential role in HIV entry into the host cell.
- gp120: The gp120 subunit is the component of the envelope that interacts with the host receptors and coreceptors these interactions involve the gp120 CD4 binding site on the outermost surface of gp120 and the more internal variable 3 region of gp120. The gp120 V3 region plays a major role in determining the coreceptor tropism of HIV.
- gp41: The gp41 subunit consists of three domains: ectodomain , the transmembrane domain , and the cytoplasmic tail . The gp41 ectodomain has several functional components that include the N-terminal hydrophobic region and the N-terminal heptad repeat region 1 and the heptad repeat region 2 . Prior to cell binding, the HIV gp41 exist in a conformation in which the gp41 is folded back on itself in an energy loaded state.
HIV Entry Inhibitors
The FDA-approved HIV entry inhibitors includes three subclasses: CD4 postattachment inhibitor, CCR5 coreceptor antagonists, and fusion inhibitors each one of these subclasses of entry inhibitors has one FDA-approved drug.
Advances In Hiv Treatment Dramatically Increase Life Expectancy
Research finds life expectancy of treated HIV-positive individuals approaches that of general populationin Canada and U.S.
Vancouver, B.C. An individual in North America beginning HIV treatment can now expect to live into their early 70s, a dramatic increase from just over 10 years ago, according to a new study from a collaboration of researchers led by the BC Centre for Excellence in HIV/AIDS .
The life expectancies of nearly 23,000 individuals on antiretroviral therapy were calculated based on mortality rates in the early to mid-2000s. There were 1,622 deaths recorded over 82,022 person-years for an overall mortality rate of 19.8 per 1,000 person-years. Researchers found that life expectancy for HIV-positive individuals at age 20 increased from 36.1 to 51.4 years between the periods of 20002002 and 20062007, meaning life expectancy is now approaching that of the general population.
Since the introduction of highly active antiretroviral therapy in 1996, treatment has become simpler, more effective, and better tolerated, leading to significant improvement in health outcomes, said Dr. Julio Montaner, director of the BC-CfE. Treatment advances mean HIV is now a chronic, manageable disease. Expanding access to treatment to all people living with HIV should be our number one priority.
The study, Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada, was published today in PLOS ONE.
Also Check: How Do You Know You Have Hiv Aids
When To Start Hiv Treatment
Its now recommended that everyone diagnosed with HIV starts treatment straight away after being diagnosed.
In the UK, national guidelines set out standards for HIV treatment. They currently recommend that anyone with HIV who is ready to commit to treatment should start it regardless of their CD4 count .
Girls Hiv Infection Seems Under Control Without Aids Drugs
Experts caution that this news should not be interpreted as having found a cure for everyone with HIV.
It doesnt change things for the average person with HIV right now, said Dr. Bruce Walker, the director of the Ragon Institute, a research institute affiliated with Massachusetts General Hospital, Harvard, and MIT that specializes in HIV/AIDS and infectious diseases. It does change things in terms of the research agenda, because it further indicates that this is a potentially viable pathway forward to achieve a cure.
That potentially viable pathway runs through a receptor called CCR5. CCR5 is one of a handful of receptors that HIV can use to get into a particular kind of cell.
Those cells, called CD4-positive T cells, are vital to a persons immune system. You can sort of think of cells as the generals that are helping to orchestrate an effective defense, Walker said. If theyre not there, things tend to go haywire.
Some people have a particular mutation in the genes that encode the CCR5 receptor that prevents the HIV virus from using it to get in to these T cells and no entry means no infection.
Recommended Reading: What Must An Insurer Obtain To Conduct An Hiv Test
What Kinds Of Drugs Are Available
HIV drugs are also called antiretroviral drugs or antiretrovirals . A whole treatment regimen is called antiretroviral therapy, or ART. The ARVs work because they attack the HIV virus directly–they cripple the ability of the virus to make copies of itself. Usually an ART regimen consists of 3 different medicines from at least 2 classes of drugs. This is because it takes a powerful combination of medicines to suppress the HIV virus.
There are 5 main classes of HIV drugs:
- Nucleoside Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Integrase Inhibitors
- Protease Inhibitors
- Entry Inhibitors
Each group attacks HIV in its own way and helps your body fight the infection. Most of these drugs come as tablets or capsules. Several of these drugs may be combined into one tablet to make it easier to take your medications. These are known as fixed-dose combinations or single tablet regimens.
The following is a short description of how each group of drugs works.
Achieving An Effective Vaccine For Hiv
An HIV vaccine is a more realistic prospect today than a decade ago. Studies have shown some evidence that current vaccine designs can produce strong immune responses that protect some people against HIV infection. Results from larger studies between 2021 and 2022 are likely to provide much more information about the timescale for achieving an effective vaccine.
Recommended Reading: How Many New Hiv Infections Per Year In Us
How Should I Take My Antiretroviral Treatment
When and how you take your ART will vary depending on the specific antiretroviral drugs you take. Most antiretroviral drugs are taken once a day, with or without food. However, some drugs are taken twice a day. If this might be something you find difficult, talk to your doctor about your options.
Once you start ART its very important that you take it properly and dont miss or skip doses, as this can lead to something called HIV drug resistance, and may mean that your drugs dont work as well for you in the future. If youre finding it hard to take your treatment at the right times and in the right way, speak to your healthcare worker. They can offer you support and give you advice on how to make taking your treatment easier.
Does Art Cause Side Effects
Like most medicines, antiretroviral therapy can cause side effects. However, not everyone experiences side effects from ART. The HIV medications used today have fewer side effects, fewer people experience them, and they are less severe than in the past. Side effects can differ for each type of ART medicine and from person to person. Some side effects can occur once you start a medicine and may only last a few days or weeks. Other side effects can start later and last longer.
If you experience side effects that are severe or make you want to stop taking your HIV medication, talk to your health care provider or pharmacist before you miss any doses or stop taking the medication. Skipping doses or starting and stopping medication can lead to drug resistance, which can harm your health and limit your future treatment options.
Some side effects of ART that are most commonly reported include:
- Nausea and vomiting,
You May Like: How Do You You Have Hiv
What Are The Barriers Preventing People With Cryptococcal Meningitis From Accessing L
Gileads L-AmB product, marketed as Ambisome, is the only quality-assured L-AmB product available in the market.
Although generic companies have been working for years to develop L-AmB, they face multiple hurdles. L-AmB is not patented, but Gilead has long hidden the liposomal technology a key component of manufacturing L-AmB as a trade secret. This, combined with limited availability of raw materials and challenging regulatory pathways, has significantly delayed generic competition.
The absence of generic manufacturers has resulted in a lack of sustainable supply of L-AmB. Access to L-AmB also remains extremely limited in low- and middle-income countries for several additional reasons:
Gilead has failed to provide sufficient access to the treatment at the access price of US$16.25 promised for 116 countries, as announced in September 2018. For example, although India and South Africa are on the list of the countries eligible for Gileads access price, the treatment is not easily available at that price in either country. Gilead is not the market authorisation holder in these countries. Instead they signed exclusive license distribution agreements with local suppliers, leaving these countries prices set by Gileads marketing partners. The price of L-AmB in these markets can range between $70-205 per vial, and local suppliers are reluctant to fulfil Gileads obligation to supply L-AmB at the access price.
Does Antiretroviral Treatment Have Side
As with all medication, starting to take ARVs can cause some side-effects, particularly in the first few days of treatment. This is another topic you could discuss with your doctor, as it might also affect your choice of drugs. Your treatment will be monitored and you may be recommended to switch drugs if they aren’t working for you or if you’re finding the side effects difficult to manage.
Don’t Miss: How Effective Are Condoms Against Hiv
A Note About Treatment
While theres currently no cure for HIV, treatments have come an incredibly long way since the virus was first identified. Due to advances in treatment, people living with HIV can have long, healthy lives.
There are now many types of antiretroviral drugs available to treat HIV. According to the National Institutes of Health , taking antiretroviral medications each day as directed can reduce viral load to undetectable levels in 6 months or less .
Not only can having an undetectable viral load keep the immune system healthy, but it can also prevent transmission of HIV to others. People with an undetectable viral load have no risk of transmitting HIV to their partners via sex.
The Challenge Of Curing Hiv
Because of the nature of HIV, discovering a cure comes with some specific challenges. The most significant of these challenges is the viruss ability to hide itself and lay dormant in pockets of host cells that are unrecognised as harbouring HIV by the immune system. Even if an individual has successfully suppressed their HIV through ARV treatment, the hidden HIV, called the latent reservoir, can re-emerge if ARV treatment is stopped.
Because of this underlying barrier, examples of HIV cure have been few and far between throughout the entire history of the HIV epidemic. In fact, there have been only two instances of confirmed HIV cure, in which HIV cannot be found in in blood or biopsies of two PLHIV , and these patients went on to successfully stop daily ARV treatment and did not experience a rebound in their HIV. 1
These individuals were cured of their HIV after treatment for their separate cancer diagnosis, which required a series of difficult and intensive treatments. While their treatments were extremely high risk and not amenable to wide scale implementation, these instances of cure bring hope of what is possible in our efforts to end the HIV epidemic.
Also Check: How To Take Hiv Test At Home
Health Problems Caused By Untreated Hiv/aids
It often takes several years for a person infected with HIV to develop full-blown AIDS. During this time, treatment options are available that can delay or stop the disease progression for many years. There is no cure for HIV, so an infected individual will always have the virus, even if they are undergoing treatment. Despite the lack of a cure, a patient can still maintain a high quality of life as long as the disease is managed with medication. Currently, combined antiretroviral therapies exist for the treatment of HIV. These therapies are able to dramatically slow viral replication and disease progression, thus delaying the onset of AIDS. For some patients, this treatment can delay disease progression for several decades. The current ability to effectively stop the development of AIDS in HIV-positive individuals makes effective adherence to medications and avoidance of complicating factors, such as substance abuse, critical to maintaining a high quality of life.
Because HIV infection reduces immune function, many other types of infections are an ongoing concern for HIV/AIDS patients. In particular, viral hepatitis is a concern because of the similar modes of transmission and prevalence of each disease within the same populations 5.